RK
Rohit Kumar Shrivastav
About Rohit Kumar Shrivastav
Data last updated:
Rohit Kumar Shrivastav is a Managing Director at Granite Pharmaceuticals Private Limited (since 2014) and Director at Zuventa Pharmaceuticals Private Limited (since 2022). The companies operate in Trading and Chemicals. The largest current company by reported revenue is Granite Pharmaceuticals Private Limited at ₹96,921 (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Managing Director | 16 Dec 2014 | 2014 | ₹96,921 (FY 2025) | Active | |
| Director | 28 Jun 2022 | 2022 | Active |
Board colleagues of Rohit Kumar Shrivastav
| Name | DIN | Company | Designation |
|---|---|---|---|
| Kumar Shailesh | 07040898 | Granite Pharmaceuticals Private Limited | Director |
| Amrita Kumari | 09655693 | Zuventa Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Rohit Kumar Shrivastav
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rohit Kumar Shrivastav
Rohit Kumar Shrivastav currently holds 2 directorships: Granite Pharmaceuticals Private Limited (Managing Director, since 16 Dec 2014, revenue ₹96,921 (FY 2025)); Zuventa Pharmaceuticals Private Limited (Director, since 28 Jun 2022).
Rohit Kumar Shrivastav was first appointed on 16 Dec 2014 as Managing Director at Granite Pharmaceuticals Private Limited. The most recent appointment on record is 28 Jun 2022 at Zuventa Pharmaceuticals Private Limited.
The current boards of Rohit Kumar Shrivastav's companies include Kumar Shailesh (Granite Pharmaceuticals Private Limited), Amrita Kumari (Zuventa Pharmaceuticals Private Limited).